Related Experiment Video
Updated: Apr 26, 2026

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
Published on: December 12, 2011
"Companion diagnostics": has their time come and gone?
Fred R Hirsch1, Paul A Bunn2, Roy S Herbst3
1Department of Medicine and Pathology, University of Colorado Cancer Center, Aurora, Colorado. fred.hirsch@ucdenver.edu.
Companion diagnostics are crucial for targeted cancer therapies but can cause delays. This study questions whether negative results in advanced non-small cell lung cancer trials were due to the drug or the companion diagnostic.
Area of Science:
- Oncology
- Pharmacology
- Biomarkers
Background:
- The rapid advancement of molecularly targeted drugs necessitates the concurrent development of companion diagnostics.
- Companion diagnostics can potentially delay drug development and restrict patient access to effective treatments.
Purpose of the Study:
- To investigate whether negative outcomes in MetMab studies for advanced non-small cell lung cancer (NSCLC) resulted from drug inefficacy or the inadequacy of the companion diagnostic used.
Main Methods:
- Review of MetMab clinical trial data in advanced NSCLC patients.
- Analysis of the performance and appropriateness of the companion diagnostic employed in the MetMab studies.
Main Results:
- Negative trial results may stem from issues with the companion diagnostic rather than the therapeutic agent itself.
- The study highlights the critical role of accurate companion diagnostics in interpreting clinical trial outcomes.
Conclusions:
- The efficacy of targeted therapies like MetMab in NSCLC is heavily reliant on the precision of companion diagnostics.
- Re-evaluation of diagnostic strategies is essential to ensure appropriate patient selection and avoid premature drug discontinuation.
Related Concept Videos
Automated Microbial Diagnostics
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Serum Laboratory Studies, Stool Test, Breath Test
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...

